Aspirus believes
that patients come first. Because our patients are our number one
priority, we are committed to participating in clinical trials that offer hope
when other medical interventions have been inadequate, intolerable, or viable
options don’t currently exist.
This month is
National Cancer Research Month. Aspirus continues to look for ways they can
further cancer treatment by contributing to cancer research and offering
patients advanced medical treatment through clinical trials that are suitable
for each patient.
Aspirus is part of
an organization called CROWN, The Cancer Research of Wisconsin and Northern
Michigan Consortium. A collaboration of three of Wisconsin’s largest cancer
treatment programs that provide medical research for clinical trials. Through
CROWN, more than 2,000 people have been successfully enrolled.
“We believe that we
should give our patients therapies that are better than the standard of
care”, says Dr. Andrew Huang, Aspirus Radiation Oncologist and Aspirus CROWN
Jr. Principal Investigator. “Not only do our patients get the chance to get the
future standard of care 5-10 years early, but their participation changes
medicine for the better.”
All clinical trials
go through extensive research and each patient is closely observed by a
research nurse – who provides concierge-type nursing. Patients can rest assured
knowing that there is always someone who can answer their questions.
Clinical trials
focus on new cancer treatments, controlling cancer symptoms, cancer screenings,
preventing and monitoring cancer and evaluating how cancer care is delivered.
Clinical trials are
currently being offered at Aspirus Wausau, Aspirus Riverview, Aspirus Langlade
and Aspirus Medford Cancer Centers. Aspirus Stevens Point Cancer Care will be
offering clinical trials in the future.
For more information
about Aspirus Clinic Trials visit www.aspirus.org/clinical-trials.